sees qtr-three adjusted earnings per share $num-one to $num - two excluding items.
qtr-two adjusted earnings per share $num-two.
qtr-four adjusted earnings per share $num-two excluding items.
sees fy year-six capital expenditures $num-one million to $2.0 billion.
qtrly adjusted ebitda increased num-one% to $num-two million.
qtrly core sales growth of num-one%.
qtrly core sales to personal care market decreased num-one%.
qtr-four sales rose num-one percent to $1.9 billion.
qtrly net sales increased num-one% on a constant currency basis.
qtrly core sales to the prescription market decreased num-one%.
compname reports third quarter year-six results and announces num-one% increase in common stock dividend.
qtrly core sales increased num-one%.
qtrly core sales to beauty market increased num-one%.
sees qtr-three year-six earnings per share to be in range of $num-one to $2.00.
qtrly core sales of active material science solutions increased num-one%.
sees fy year-six sales up num-one% to $num-one billion.
